Stifel analysts maintained a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) with a steady price target of $21.00. According to InvestingPro data, the stock currently trades at $6.40, with analyst ...

The team of three advisors have started a firm called T6 Wealth Management, which will operate out of Morgan Stanley's new ...

Stifel Financial Corp (NYSE:SF). has announced a revision to its executive compensation structure, according to a recent SEC filing. On Monday, the Compensation Committee of the Board of Directors ...

NEW YORK, January 21, 2025--(BUSINESS WIRE)--Alpaca Real Estate ("ARE"), an alternative investment management firm, announced today the closing of a $50 million credit facility with Stifel Bank. This ...

Research analysts at Stifel Canada reduced their Q4 2024 earnings estimates for Kinross Gold in a report issued on Tuesday, ...

We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Stifel Nicolaus analyst Benjamin Nolan downgraded Genco Shipping (GNK – Research Report) to a Hold yesterday and set a price target of $18.00.

(RTTNews) - Stifel Financial Corp. (SF ... Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews ...

In a report released yesterday, Matthew Smith, CFA from Stifel Nicolaus maintained a Hold rating on Hain Celestial (HAIN – Research Report), ...

ST. LOUIS (AP) — ST. LOUIS (AP) — Stifel Financial Corp. (SF) on Wednesday reported net income of $244 million in its fourth quarter. The company, based in St. Louis, said it had earnings of $2.09 per ...